Clinical Trial Update: A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating an IL-4Rα monoclonal antibody for seasonal allergic rhinitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• IL-4Rα monoclonal antibody (Interleukin-4 receptor alpha monoclonal antibody)

Snippet

Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd. | Conditions: Allergic Rhinitis, Seasonal | Phase 3 | Status: RECRUITING